Skip to main content

Posts

Showing posts with the label hepatitis-c

Two is Better than One, Cancer Drug Could Cure HBV

A promising cure has been found which uses an anti-cancer drug along with an anti-viral drug to treat hepatitis b, and within phase 1/2a trials and has achieved 100% success. Hepatitis-B is a chronic viral disease that is currently incurable.  Over two billion people worldwide are infected with hepatitis B and approximately 400 million have a chronic HBV infection, unimaginable numbers. The virus infects liver cells and can lead to complications including cirrhosis and liver cancer, resulting in more than 780,000 deaths annually. Hepatitis B patients in Australia are the first people who will have access to the potential treatment. The scientists from Melbourne's Walter and Eliza Hall Institute researched the combination of the anti-viral drug and the anti-cancer drug (developed by a US company-TetraLogic pharmaceuticals). Dr Marc Pellegrini and Dr Greg Ebert and their colleagues at the institute utilised their research on the behaviour of Hep-B in infected cells as

Micro-needle Plasters

My previous post was on the success of research for finding a vaccine for the Hepatitis-C virus , this posts looks into a new way to prevent Hep-C along with other blood transmitted diseases in a magnificent way. Since using sharp, medical needles are risky and have been a transmitter of diseases, when used incorrectly; it’s suggested that healthcare professionals use the needle only once and with the correct procedure and is disposed of safely. But there’s also an alternative option, which is much safer and painless. Micro needles affixed to plaster are painless and safe to administer and they don’t get through to the nerves, which almost gives a Velcro-like texture. The micro-needles are made of soft contact lens like material and at their dry state, the needles are hard and can penetrate the skin (50 microns) and once in the skin, can rapidly take up fluid from the interstitial fluid, into the micro-needles, and swell.

New Hopes for Hepatitis-C Vaccine

Hepatitis-C is a worldwide virus that infects people if they come into contact with the blood of an infected person. The potent virus damages the liver by causing liver cirrhosis, usually after several years of infection, which can lead to liver cancer in cases of chronic Hepatitis-C. Even though there are many successful anti-viral treatments they can be very expensive especially in the areas that it is prevalent in: North Africa, the Middle East and Central and East Asia. Symptoms of Hepatitis-C §   Flu-like symptoms such as muscle aches and loss of appetite §   Feeling tired all the time §   Depression Hepatitis-C is spread by: §   Shared needles for vaccinations or medical treatment §   Shared needles during illegal drug injection §   Needle- stick injury via contaminated needles, in nurses and doctors who deal with Hepatitis-C carrying patients